Skip to main content

Table 2 Overall response and disease control rates (ITT population)

From: Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study

Response

n = 31

Best overall*

 

Complete

0

Partial

1 (3.2%)

Stable disease

10 (32.3%)

Progressive disease

19 (61.3%)

Not determinable

1 (3.2%)

Disease control rate†

11 (35.5%)

  1. *Summary from site and central review; †Calculated as (complete response + partial response + stable disease)/number of patients.
Back to article page